Drug Shortage Report for FLOVENT HFA
Report ID | 108714 |
Drug Identification Number | 02244291 |
Brand name | FLOVENT HFA |
Common or Proper name | fluticasone propionate inhalation aerosol |
Company Name | GLAXOSMITHKLINE INC |
Market Status | MARKETED |
Active Ingredient(s) | FLUTICASONE PROPIONATE |
Strength(s) | 50MCG |
Dosage form(s) | METERED-DOSE AEROSOL |
Route of administration | INHALATION ORAL |
Packaging size | 1x120 |
ATC code | R03BA |
ATC description | OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2020-03-09 |
Estimated end date | Unknown |
Actual end date | 2020-03-26 |
Shortage status | Resolved |
Updated date | 2020-03-27 |
Company comments | Inventory on allocation to support demand. |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2020-03-13 | English | Compare |
v2 | 2020-03-13 | French | Compare |
v3 | 2020-03-16 | English | Compare |
v4 | 2020-03-16 | French | Compare |
v5 | 2020-03-26 | English | Compare |
v6 | 2020-03-26 | French | Compare |
v7 | 2020-03-27 | English | Compare |
Showing 1 to 7 of 7